Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
10.97
0.01 (0.09%)
At close: Aug 15, 2025, 12:51 PM

Avanos Medical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
107.7M 87.7M 127.7M 118.5M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
23.2M 19.3M 17.6M 16.5M
Receivables
132.8M 142.8M 167.9M 118.2M
Inventory
138.8M 163.2M 190.3M 150.3M
Other Current Assets
14.1M 93.3M 196.2M 13M
Total Current Assets
393.4M 487M 499.8M 418.6M
Property-Plant & Equipment
144.8M 144M 194.5M 206.7M
Goodwill & Intangibles
567.9M 1.04B 1.07B 942.8M
Total Long-Term Assets
760.8M 1.21B 1.29B 1.18B
Total Assets
1.15B 1.69B 1.79B 1.59B
Account Payables
54.3M 56.3M 67.9M 56.4M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
20.3M 8.6M 6.2M 14.7M
Other Current Liabilities
73.3M 108.7M 70.3M 24.1M
Total Current Liabilities
165.9M 234.6M 185.8M 139.2M
Long-Term Debt
125.3M 159.4M 226.3M 130M
Other Long-Term Liabilities
4.4M 10M 20.5M 9.1M
Total Long-Term Liabilities
159.8M 221.5M 309.9M 191.5M
Total Liabilities
325.7M 456.1M 495.7M 330.7M
Total Debt
170.2M 209.1M 280M 187.5M
Common Stock
500K 500K 500K 500K
Retained Earnings
-707M -314.9M -253.1M -310.3M
Comprehensive Income
-44.6M -27M -35.8M -33.8M
Shareholders Equity
828.5M 1.24B 1.29B 1.26B
Total Investments
n/a n/a n/a n/a